Copyright Reports & Markets. All rights reserved.

Global Meloxicam Drug Market Insights, Forecast to 2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Meloxicam Drug Industry
  • 1.7 COVID-19 Impact: Meloxicam Drug Market Trends

    • 2 Global Meloxicam Drug Quarterly Market Size Analysis

    • 2.1 Meloxicam Drug Business Impact Assessment - COVID-19
      • 2.1.1 Global Meloxicam Drug Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Meloxicam Drug Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Meloxicam Drug Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Meloxicam Drug Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Meloxicam Drug Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Meloxicam Drug Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Meloxicam Drug Market
    • 3.5 Key Manufacturers Meloxicam Drug Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Meloxicam Drug Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Tablet
      • 1.4.2 Capsule
    • 4.2 By Type, Global Meloxicam Drug Market Size, 2019-2021
      • 4.2.1 By Type, Global Meloxicam Drug Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Meloxicam Drug Price, 2020-2021

    5 Impact of Covid-19 on Meloxicam Drug Segments, By Application

    • 5.1 Overview
      • 5.5.1 Osteoarthritis in adults (OA)
      • 5.5.2 Rheumatoid Arthritis in adults (RA)
      • 5.5.3 Pediatric patients
    • 5.2 By Application, Global Meloxicam Drug Market Size, 2019-2021
      • 5.2.1 By Application, Global Meloxicam Drug Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Meloxicam Drug Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Boehringer-Ingelheim
      • 7.1.1 Boehringer-Ingelheim Business Overview
      • 7.1.2 Boehringer-Ingelheim Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.1.3 Boehringer-Ingelheim Meloxicam Drug Product Introduction
      • 7.1.4 Boehringer-Ingelheim Response to COVID-19 and Related Developments
    • 7.2 TerSera Therapeutics
      • 7.2.1 TerSera Therapeutics Business Overview
      • 7.2.2 TerSera Therapeutics Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.2.3 TerSera Therapeutics Meloxicam Drug Product Introduction
      • 7.2.4 TerSera Therapeutics Response to COVID-19 and Related Developments
    • 7.3 Iroko Pharmaceuticals
      • 7.3.1 Iroko Pharmaceuticals Business Overview
      • 7.3.2 Iroko Pharmaceuticals Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.3.3 Iroko Pharmaceuticals Meloxicam Drug Product Introduction
      • 7.3.4 Iroko Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.4 Apotex
      • 7.4.1 Apotex Business Overview
      • 7.4.2 Apotex Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.4.3 Apotex Meloxicam Drug Product Introduction
      • 7.4.4 Apotex Response to COVID-19 and Related Developments
    • 7.5 Yung Shin Pharmaceutical
      • 7.5.1 Yung Shin Pharmaceutical Business Overview
      • 7.5.2 Yung Shin Pharmaceutical Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.5.3 Yung Shin Pharmaceutical Meloxicam Drug Product Introduction
      • 7.5.4 Yung Shin Pharmaceutical Response to COVID-19 and Related Developments
    • 7.6 Breckenridge Pharmaceutical
      • 7.6.1 Breckenridge Pharmaceutical Business Overview
      • 7.6.2 Breckenridge Pharmaceutical Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.6.3 Breckenridge Pharmaceutical Meloxicam Drug Product Introduction
      • 7.6.4 Breckenridge Pharmaceutical Response to COVID-19 and Related Developments
    • 7.7 Zydus Pharmaceuticals
      • 7.7.1 Zydus Pharmaceuticals Business Overview
      • 7.7.2 Zydus Pharmaceuticals Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.7.3 Zydus Pharmaceuticals Meloxicam Drug Product Introduction
      • 7.7.4 Zydus Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.8 Unichem Pharmaceuticals
      • 7.8.1 Unichem Pharmaceuticals Business Overview
      • 7.8.2 Unichem Pharmaceuticals Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.8.3 Unichem Pharmaceuticals Meloxicam Drug Product Introduction
      • 7.8.4 Unichem Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.9 Strides Pharma
      • 7.9.1 Strides Pharma Business Overview
      • 7.9.2 Strides Pharma Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.9.3 Strides Pharma Meloxicam Drug Product Introduction
      • 7.9.4 Strides Pharma Response to COVID-19 and Related Developments
    • 7.10 Cipla
      • 7.10.1 Cipla Business Overview
      • 7.10.2 Cipla Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.10.3 Cipla Meloxicam Drug Product Introduction
      • 7.10.4 Cipla Response to COVID-19 and Related Developments
    • 7.11 Dr. Reddy's Laboratories
      • 7.11.1 Dr. Reddy's Laboratories Business Overview
      • 7.11.2 Dr. Reddy's Laboratories Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.11.3 Dr. Reddy's Laboratories Meloxicam Drug Product Introduction
      • 7.11.4 Dr. Reddy's Laboratories Response to COVID-19 and Related Developments
    • 7.12 Glenmark Pharmaceuticals
      • 7.12.1 Glenmark Pharmaceuticals Business Overview
      • 7.12.2 Glenmark Pharmaceuticals Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.12.3 Glenmark Pharmaceuticals Meloxicam Drug Product Introduction
      • 7.12.4 Glenmark Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.13 Teva
      • 7.13.1 Teva Business Overview
      • 7.13.2 Teva Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.13.3 Teva Meloxicam Drug Product Introduction
      • 7.13.4 Teva Response to COVID-19 and Related Developments
    • 7.14 PuraCap Pharmaceutical
      • 7.14.1 PuraCap Pharmaceutical Business Overview
      • 7.14.2 PuraCap Pharmaceutical Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.14.3 PuraCap Pharmaceutical Meloxicam Drug Product Introduction
      • 7.14.4 PuraCap Pharmaceutical Response to COVID-19 and Related Developments
    • 7.15 TARO
      • 7.15.1 TARO Business Overview
      • 7.15.2 TARO Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.15.3 TARO Meloxicam Drug Product Introduction
      • 7.15.4 TARO Response to COVID-19 and Related Developments
    • 7.16 Lupin Pharmaceuticals
      • 7.16.1 Lupin Pharmaceuticals Business Overview
      • 7.16.2 Lupin Pharmaceuticals Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.16.3 Lupin Pharmaceuticals Meloxicam Drug Product Introduction
      • 7.16.4 Lupin Pharmaceuticals Response to COVID-19 and Related Developments
    • 7.17 Aurobindo Pharma
      • 7.17.1 Aurobindo Pharma Business Overview
      • 7.17.2 Aurobindo Pharma Meloxicam Drug Quarterly Production and Revenue, 2020
      • 7.17.3 Aurobindo Pharma Meloxicam Drug Product Introduction
      • 7.17.4 Aurobindo Pharma Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Meloxicam Drug Supply Chain Analysis
      • 8.1.1 Meloxicam Drug Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Meloxicam Drug Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Meloxicam Drug Distribution Channels
      • 8.2.2 Covid-19 Impact on Meloxicam Drug Distribution Channels
      • 8.2.3 Meloxicam Drug Distributors
    • 8.3 Meloxicam Drug Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Meloxicam Drug, including the following market information:
      Global Meloxicam Drug Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Meloxicam Drug Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Meloxicam Drug Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K MT)
      Global Meloxicam Drug Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K MT)

      Key market players
      Major competitors identified in this market include Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals, Apotex, Yung Shin Pharmaceutical, Breckenridge Pharmaceutical, Zydus Pharmaceuticals, Unichem Pharmaceuticals, Strides Pharma, Cipla, Dr. Reddy's Laboratories, Glenmark Pharmaceuticals, Teva, PuraCap Pharmaceutical, TARO, Lupin Pharmaceuticals, Aurobindo Pharma, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Tablet
      Capsule

      Based on the Application:
      Osteoarthritis in adults (OA)
      Rheumatoid Arthritis in adults (RA)
      Pediatric patients

      Buy now